FindTrial
Sign In

Evaluation of the efficacy of MgSO4 on labour analgesia

Evaluation of the efficacy of MgSO4 as an adjunct to ropivacaine and fentanyl for labour analgesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/09/015594
Enrollment
60
Registered
2018-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Primigravida

Interventions

Intervention1: Ropivacaine plus fentanyl: 7.5ml 0.2% Ropivacaine with 1mcg/kg fentanyl given via epidural catheter Intervention2: Ropivacaine plus fentanyl plus MgSO4: 7.5ml 0.2% Ropivacaine with 1mcg

Sponsors

Maharana Bhupal Government Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Primi parturients In active labour requesting labour analgesia

Exclusion criteria

Exclusion criteria: Parturient refusal Coagulopathy Infection at puncture site Hypersensitivity to study drugs pregnancy induced hypertension Breech presentation Multiparity Gestational diabetes

Design outcomes

Primary

MeasureTime frame
To evaluate the adjuvant effect of single dose MgSO4 administered epidurally with ropivacaine and fentanyl for labour analgesiaTimepoint: 5mins, 10mins, 15mins, 30mins, 60mins and 1hrly uptil time of delivery—

Secondary

MeasureTime frame
To assess the effect of MgSO4 on neonatal outcomeTimepoint: 5mins, 10mins, 15mins, 30mins, 60mins and 1hrly uptil time of delivery—

Countries

India

Contacts

Public ContactMegha Gupta

RNT Medical College

dr_ikumari@hotmail.com9414176760

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026